Robert H. Collins Jr.
Director of the Hematologic Malignancies and Cellular Therapy Program · UT Southwestern Medical Center
Credentials: · · ·
History
PresentHematologic Malignancies and Cellular Therapy Program · UT Southwestern Medical Center
- Present
Combined Adult/Pediatric Stem Cell Transplant Program · UT Southwestern Medical Center
- 1987–1989
UCLA
- 1984–1987
Research
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML
New England Journal of Medicine · 2018 · 1,234 citations
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Blood · 2017 · 1,232 citations
Functional genomic landscape of acute myeloid leukaemia
Nature · 2018 · 1,111 citations
25 papers
- JF
24 papers
19 papers
17 papers
- PP
17 papers
15 papers
- ES
13 papers
13 papers
